Skip to Content

Lenalidomide

In the US, Lenalidomide (lenalidomide systemic) is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants and is used to treat Anemia, Follicular Lymphoma, Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma and Myelodysplastic Diseases.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AX04

CAS registry number (Chemical Abstracts Service)

0191732-72-6

Chemical Formula

C13-H13-N3-O3

Molecular Weight

259

Therapeutic Categories

Cytostatic agent

Immunomodulator

Angiogenesis inhibitor

Chemical Names

(3RS)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidin-2,6-dion (IUPAC)

(3RS)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione (WHO)

Foreign Names

  • Lenalidomidum (Latin)
  • Lenalidomid (German)
  • Lenalidomide (French)
  • Lenalidomida (Spanish)

Generic Names

  • Lenalidomide (OS: BAN, USAN)
  • CC-5013 (Cellgene-Corporation) (IS)
  • CC-5053 (IS)
  • CDC-5013 (IS)
  • ENMD-0997 (IS)
  • IMiD3 (IS)

Brand Names

  • Bomilen
    AC Farma, Peru
  • Hemalen
    Ivax, Argentina
  • Ladevina
    LKM Peru, Peru
  • Ladevina 10
    LKM, Argentina
  • Ladevina 15
    LKM, Argentina
  • Ladevina 25
    LKM, Argentina
  • Ladevina 5
    LKM, Argentina
  • Ledamin
    Aspen, Argentina
  • Lenalid
    Pharma Roy, Peru
  • Lenalidomide
    Teva, United Kingdom
  • Lenalidomide Sandoz
    Sandoz, United Kingdom
  • Lenalidomide-Humanity
    BDR Pharmaceuticals, Georgia
  • Lenalinova
    Celnova, Argentina
  • Lenomel 10
    Dosa, Argentina
  • Lenomel 15
    Dosa, Argentina
  • Lenomel 25
    Dosa, Argentina
  • Lenomel 5
    Dosa, Argentina
  • Lunadin
    Tuteur, Argentina
  • Mizarid
    Everex-Oriental, Argentina
  • Myelenz
    Bioprofarma, Argentina
  • Renged
    Kemex, Argentina
  • Revlimid
    Asofarma de Mexico, Mexico; Celgene, Australia; Celgene, Belgium; Celgene, Canada; Celgene, China; Celgene, Czech Republic; Celgene, Estonia; Celgene, Egypt; Celgene, Spain; Celgene, Finland; Celgene, France; Celgene, United Kingdom; Celgene, Greece; Celgene, Hong Kong; Celgene, Ireland; Celgene, Italy; Celgene, Japan; Celgene, Lithuania; Celgene, Latvia; Celgene, Netherlands; Celgene, Norway; Celgene, New Zealand; Celgene, Poland; Celgene, Sweden; Celgene, Turkey; Celgene, United States; Celgene Europe, Bosnia & Herzegowina; Celgene Europe, Cyprus; Celgene Europe, Serbia; Celgene Europe, Slovenia; Celgene Europe Limited, Iceland; Celgene Europe Limited, Tunisia; Celgene International, Oman; Celgene Nordic, Denmark; Medical Intertrade, Croatia (Hrvatska); Medicamenta Ecuatoriana, Ecuador; Penn Pharmaceutical Services, Serbia; Penn Pharmaceuticals, Macedonia; Raffo, Argentina; Tecnofarma, Chile; Tecnofarma, Peru
  • Revlimid 10 mg
    Celgene, Hungary
  • Revlimid 10mg
    Celgene, Switzerland; Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Revlimid 15 mg
    Celgene, Hungary
  • Revlimid 15mg
    Celgene, Switzerland; Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Revlimid 2.5mg
    Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Revlimid 20mg
    Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Revlimid 25 mg
    Celgene, Hungary
  • Revlimid 25mg
    Celgene, Switzerland; Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Revlimid 5 mg
    Celgene, Hungary
  • Revlimid 5mg
    Celgene, Switzerland; Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Revlimid 7.5mg
    Celgene, Germany; Celgene, Israel; Celgene, Luxembourg; Celgene Europe, Austria
  • Rivelime
    Deva, Turkey

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.